Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Autonomic effects of a series of phenylalkylamine derivatives.

PINDELL MH, FINNEGAN JK, SMITH JD.

J Med Pharm Chem. 1961 Jan 10;3:167-82. No abstract available.

PMID:
14486717
2.

Effects of adding gamma-irradiated green beans or fruit compote to the diet of dogs.

LARSON PS, BELTER LF, CRAWFORD EM, HAAG HB, FINNEGAN JK, SMITH RB Jr.

Toxicol Appl Pharmacol. 1961 Jan;3:57-62. No abstract available.

PMID:
13759216
3.

Chronic toxicity studies on two epoxidized soybean oils in the rat and dog.

LARSON PS, FINNEGAN JK, HAAG HB, SMITH RB Jr, HENNIGAR GR.

Toxicol Appl Pharmacol. 1960 Nov;2:649-58. No abstract available.

PMID:
13759218
4.

Chronic toxicologic studies on isopropyl N-(3-chlorophenyl) carbamate (CIPC).

LARSON PS, CRAWFORD EM, SMITH RB Jr, HENNIGAR GR, HAAG HB, FINNEGAN JK.

Toxicol Appl Pharmacol. 1960 Nov;2:659-73. No abstract available.

PMID:
13759217
5.

Pharmacological studies of some amino ethers derived from certain arylalkanols.

FRANKO BV, FINNEGAN JK.

Arch Int Pharmacodyn Ther. 1960 Aug 1;127:1-10. No abstract available.

PMID:
13701448
6.

Studies on the acute toxicity and irritating properties of the congeners in whisky.

HAAG HB, FINNEGAN JK, LARSON PS, SMITH RB Jr.

Toxicol Appl Pharmacol. 1959 Nov;1:618-27. No abstract available.

PMID:
13830581
7.

Toxicity studies on dichlorophenyl benzenesulfonate.

SMITH RB Jr, DEICHMANN WB, HENNIGAR GR, FINNEGAN JK, HAAG HB, LARSON PS.

Arch Int Pharmacodyn Ther. 1959 Sep 1;121:306-17. No abstract available.

PMID:
13832128
8.

Toxicologic studies on 2,2-bis-(chlorophenyl)-2,2, 2-trichloroethanol (kelthane).

SMITH RB Jr, LARSON PS, FINNEGAN JK, HAAG HB, HENNIGAR GR, COBEY F.

Toxicol Appl Pharmacol. 1959 Mar;1(2):119-34. No abstract available.

PMID:
13635680
9.

Acute and chronic toxicity studies on 2, 4-dinitro-6-(1-methylheptyhepty1)-phenyl crotonate (karathane).

LARSON PS, FINNEGAN JK, SMITH RB Jr, HAAG HB, HENNIGAR GR, PATTERSON M.

Arch Int Pharmacodyn Ther. 1959 Mar 1;119(1-2):31-42. No abstract available.

PMID:
13628265
10.

Effect of filtration on the chemical and irritating properties of cigarette smoke.

HAAG HB, LARSON PS, FINNEGAN JK.

AMA Arch Otolaryngol. 1959 Mar;69(3):261-5. No abstract available.

PMID:
13626313
11.

Acute and chronic toxicity studies on pentachloronitrobenzene.

FINNEGAN JK, LARSON PS, SMITH RB Jr, HAAG HB, HENNIGAR GR.

Arch Int Pharmacodyn Ther. 1958 Feb 1;114(1):38-52. No abstract available.

PMID:
13522290
12.

Observations on the effects of chemical configuration on the edema-producing potency of acids, aldehydes, ketones and alcohols.

LARSON PS, FINNEGAN JK, HAAG HB.

J Pharmacol Exp Ther. 1956 Jan;116(1):119-22. No abstract available.

PMID:
13296026
13.

Observations on the relation of chemical structure to the production of adrenal cortical atrophy or hypertrophy in the dog by derivatives of 2, 2-bis-(p-chlorophenyl)-1, 1-dichloroethane (DDD, TDE).

LARSON PS, HENNIGAR GR, FINNEGAN JK, SMITH RB Jr, HAAG HB.

J Pharmacol Exp Ther. 1955 Dec;115(4):408-12. No abstract available.

PMID:
13272193
14.

Acute and chronic toxicity studies on 2,2-bis-(p-ethylphenyl)-1,1-dichloroethane (perthane).

FINNEGAN JK, HENNIGAR GR, SMITH RB Jr, LARSON PS, HAAG HB.

Arch Int Pharmacodyn Ther. 1955 Oct 15;103(4):404-18. No abstract available.

PMID:
13283630
15.

Pharmacologic observations on two quaternary ammonium germicides.

FINNEGAN JK, LARSON PS, SMITH RB Jr, HAAG HB, REID JD, DREYFUSS ML.

J Pharmacol Exp Ther. 1953 Dec;109(4):422-30. No abstract available.

PMID:
13109708
16.

Toxicologic studies on zinc and disodium ethylene bisdithiocarbamates.

SMITH RB Jr, FINNEGAN JK, LARSON PS, SAHYOUN PF, DREYFUSS ML, HAAG HB.

J Pharmacol Exp Ther. 1953 Oct;109(2):159-66. No abstract available.

PMID:
13097347
17.

Comparative chronic toxicity for warm-blooded animals of 2,2-bis-(p-chlorophenyl)-1,1,1-trichloroethane (DDT) and 2,2-bis-(p-methoxyphenyl)-1,1,1-trichloroethane (DMDT, methoxychlor).

HAAG HB, FINNEGAN JK, LARSON PS, RIESE W, DREYFUSS ML.

Arch Int Pharmacodyn Ther. 1950 Sep 1;83(4):491-504. No abstract available.

PMID:
14777600
18.

Observations on the pharmacology of nicotyrine.

LARSON PS, FINNEGAN JK, VAN SLYKE CB, HAAG HB.

Arch Int Pharmacodyn Ther. 1950 Jun 1;83(1):191-2. No abstract available.

PMID:
15426382
19.

Note on the Protective Action of Diparcol against Lethal Doses of Nicotine.

Larson PS, VAN Slyke CB, Finnegan JK, Haag HB.

Science. 1950 Apr 28;111(2887):476. No abstract available.

PMID:
17809389
20.

Observations on the effect of cigarette smoking on the fusion frequency of flicker.

LARSON PS, FINNEGAN JK, HAAG HB.

J Clin Invest. 1950 Apr;29(4):483-5. No abstract available.

21.

Tissue distribution and elimination of DDD and DDT following oral administration to dogs and rats.

FINNEGAN JK, HAAG HB, LARSON PS.

Proc Soc Exp Biol Med. 1949 Nov;72(2):357-60. No abstract available.

PMID:
15398310
22.

Cigarette smoke irritation; the efficiency of filters in reducing its intensity.

HAAG HB, FINNEGAN JK, LARSON PS.

Arch Otolaryngol. 1949 Jul;48(1):41-6. No abstract available.

PMID:
18113038
23.

Studies on the fate of nicotine in the body; observations on the relative rate of elimination of nicotine by the dog, cat, rabbit and mouse.

LARSON PS, FINNEGAN JK, HAAG HB.

J Pharmacol Exp Ther. 1949 Apr;95 P(4):506-8. No abstract available.

PMID:
18131240
24.
25.

Comparative tolerance of dogs, cats and rabbits to nicotine.

FINNEGAN JK, LARSON PS, HAAG HB.

Fed Proc. 1948 Mar;7(1 Pt 1):218. No abstract available.

PMID:
18938336
26.

Observations on the comparative pharmacologic actions of 6-dimethylamino-4,4-diphenyl-3-heptanone (amidone) and morphine.

FINNEGAN JK, HAAG HB, et al.

J Pharmacol Exp Ther. 1948 Mar;92(3):269-76. No abstract available.

PMID:
18907213
27.
28.

Studies on cigarette smoke irritation; the role of nicotine.

FINNEGAN JK, LARSON PS, HAAG HB.

Proc Soc Exp Biol Med. 1947 Jun;65(2):200-2. No abstract available.

PMID:
20250436
29.

Studies on cigarette smoke irritation; determination of edema-producing properties of certain types of cigarette tobaccos.

LARSON PS, HAAG HB, FINNEGAN JK.

Proc Soc Exp Biol Med. 1947 Apr;64(4):476-8. No abstract available.

PMID:
20239463
30.

A quantitative method for the measurement of cigarette smoke irritation.

FINNEGAN JK, FORDHAM D, et al.

J Pharmacol Exp Ther. 1947 Feb;89(2):115-24. No abstract available.

PMID:
20285831
31.

Observations on the relation of dose of nicotine administered to the percentage excreted unchanged.

LARSON PS, FINNEGAN JK, HAAG HB.

Fed Proc. 1947;6(1):348. No abstract available.

PMID:
20343727
32.

Pharmacologic observations on 1,1-diphenyl-1 (dimethyl-aminoisopropyl)-butanone-2.

HAAG HB, FINNEGAN JK, LARSON PS.

Fed Proc. 1947;6(1):334. No abstract available.

PMID:
20343696
33.

Observations on the role of nicotine in cigarette smoke irritation.

FINNEGAN JK, LARSON PS, HAAG HB.

Fed Proc. 1947;6(1):329. No abstract available.

PMID:
20343685
34.

Studies on the fate of nicotine in the body; observations on the chemical structure of an end product of nicotine metabolism.

LARSON PS, HAAG HB, FINNEGAN JK.

J Pharmacol Exp Ther. 1946 Mar;86:239-41. No abstract available.

PMID:
21020044
35.

Studies on factors influencing the toxicity of nicotine; the effects of water and food deprivation; disturbed liver function and rate of administration.

HAAG HB, LARSON PS, FINNEGAN JK.

J Pharmacol Exp Ther. 1945 Dec;85:356-62. No abstract available.

PMID:
21010745
36.

THE ROLE OF NICOTINE IN THE CIGARETTE HABIT.

Finnegan JK, Larson PS, Haag HB.

Science. 1945 Jul 27;102(2639):94-6. No abstract available.

PMID:
17813941
37.

A CONVENIENT METHOD OF LABELING BOTTLES.

Gurchot C, Finnegan JK.

Science. 1941 Mar 21;93(2412):288. No abstract available.

PMID:
17834801

Supplemental Content

Loading ...
Support Center